These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 6031447)

  • 41. [Results of the vaccination against measles with a use of a live vaccine in Rowno and in Rowno district].
    Levchenko IF
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():411-5. PubMed ID: 5860961
    [No Abstract]   [Full Text] [Related]  

  • 42. [Measles-mumps-rubella vaccination. Objective: 90% vaccinal coverage at 2 years of age in France].
    Lacronique JF; Janvrin MP
    Sante; 1994; 4(3):213. PubMed ID: 7921690
    [No Abstract]   [Full Text] [Related]  

  • 43. [The eradication of measles by general vaccination is beneficial and feasible].
    Rey M
    Ann Pediatr (Paris); 1984 Jun; 31(6):483-7. PubMed ID: 6380378
    [No Abstract]   [Full Text] [Related]  

  • 44. Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003.
    Asatryan A; Pool V; Chen RT; Kohl KS; Davis RL; Iskander JK;
    Vaccine; 2008 Feb; 26(9):1166-72. PubMed ID: 18255204
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of herd immunity in control of measles.
    Black FL
    Yale J Biol Med; 1982; 55(3-4):351-60. PubMed ID: 7180027
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Measles outbreak in western Sydney. Vaccine failure or failure to vaccinate?
    McDonnell LF; Jorm LR; Patel MS
    Med J Aust; 1995 May; 162(9):471-5. PubMed ID: 7746203
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Time of the appearance of immunity to measles after the administration of a live measles vaccine].
    Revenok ND
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():355-60. PubMed ID: 5860953
    [No Abstract]   [Full Text] [Related]  

  • 48. [Electroencephalographic and clinical observations in active measles vaccination with attenuated live vaccine].
    Müller K; Eckoldt G
    Dtsch Gesundheitsw; 1966 Jan; 21(2):70-6. PubMed ID: 5940860
    [No Abstract]   [Full Text] [Related]  

  • 49. [Immunization against measles in the GDR and current results of the program to combat measles].
    Starke G; Gerike E; Hlinak P
    Z Gesamte Hyg; 1980; 26(12):881-5. PubMed ID: 7234002
    [No Abstract]   [Full Text] [Related]  

  • 50. Anti-measles vaccines.
    Stones PB
    Rev Invest (Guadalajara); 1965 Apr; 5(1):36-41. PubMed ID: 5829922
    [No Abstract]   [Full Text] [Related]  

  • 51. [Program for carrying out a campaign of controlled measles vaccination in a local area].
    Santoro R; Polo M; Rigoli E; Scardellato U; Annesi I; Grandolfo ME; Novello F
    Ann Ist Super Sanita; 1982; 18(3):441-4. PubMed ID: 7187830
    [No Abstract]   [Full Text] [Related]  

  • 52. Says many children still unnecessarily have measles.
    Agate GH
    Mich Med; 1967 Feb; 66(3):208. PubMed ID: 6037141
    [No Abstract]   [Full Text] [Related]  

  • 53. Population immunity to measles in the United States, 1999.
    Hutchins SS; Bellini WJ; Coronado V; Jiles R; Wooten K; Deladisma A
    J Infect Dis; 2004 May; 189 Suppl 1():S91-7. PubMed ID: 15106096
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Measles immunity in Israeli young adults: effects of second immunization at 18 years of age.
    Olsha M; Mendelson E; Shohat T; Cohen D; Duvdevani P; Lerman Y; Danon YL
    Isr J Med Sci; 1994 Aug; 30(8):596-9. PubMed ID: 8045739
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A 24-year review on the epidemiology and control of measles in Singapore, 1981-2004.
    Ong G; Hoon HB; Ong A; Chua LT; Kai CS; Tai GK
    Southeast Asian J Trop Med Public Health; 2006 Jan; 37(1):96-101. PubMed ID: 16771219
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Results of the use of the live measles vaccine of the Leningrad Pasteur Institute of Epidemiology and Microbiology in Alma-Ata].
    Rozhnov VF
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():388-94. PubMed ID: 4221935
    [No Abstract]   [Full Text] [Related]  

  • 57. [The cell-mediated response after measles vaccination].
    Pala S; Crimaldi G; Consolini R; Macchia P
    Pediatr Med Chir; 1998; 20(3):213-6. PubMed ID: 9744016
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Measles vaccination coverage during poliomyelitis national immunization days in Burkina Faso, 1999.
    Yaméogo KR; Yaméogo A; Nacoulma SD; Zuber PL
    J Infect Dis; 2003 May; 187 Suppl 1():S74-9. PubMed ID: 12721895
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [The nature of some reactogenic properties of a live measles vaccine].
    Kurashvili VE; Meparishvili KG; Mateshvili ES
    Tr Leningr Nauchnoissled Inst Epidemiol Mikrobiol; 1965; 28():197-205. PubMed ID: 5317833
    [No Abstract]   [Full Text] [Related]  

  • 60. Influence of the specific T cell response on seroconversion after measles vaccination in autologous bone marrow transplant patients.
    Pauksen K; Linde A; Lönnerholm G; Ljungman P; Sjölin J
    Bone Marrow Transplant; 1996 Nov; 18(5):969-73. PubMed ID: 8932853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.